News

@Weeklyvoice
weeklyvoice. com > 4kira4moms-announces-melanie-fiona-to-headline-black-maternal-health-week-block-party-pampers-joins-as-diamond-sponsor

4 Kira4 Moms Announces Melanie Fiona to Headline Black Maternal Health Week Block Party, Pampers Joins as Diamond Sponsor

10+ hour, 33+ min ago  (500+ words) ATLANTA, GA, UNITED STATES, April 9, 2026 /EINPresswire. com/ " 4 Kira4 Moms proudly announces the activities and guests for the 4th Annual Black Maternal Health Week Block Party, taking place on Saturday, April 11, 2026, from 10: 00 a. m. to 3: 30 p. m. , in partnership with the City of Atlanta, Mayor Andre Dickens…...

@Weeklyvoice
weeklyvoice. com > cosmofactor-launches-its-latest-range-of-premium-haircare-skincare-makeup-and-bath-body-products

Cosmo Factor Launches Its Latest Range of Premium Haircare, Skincare, Makeup, and Bath & Body Products | Weekly Voice

1+ week, 1+ day ago  (193+ words) The haircare category showcases an extensive lineup of shampoos, conditioners, masks, toning treatments, styling creams, sprays, and hair color products. Customers can find solutions for color-treated hair, dry and damaged strands, curl definition, volume enhancement, and scalp care. Cosmo Factor…...

@Weeklyvoice
weeklyvoice. com > flourish-care-raises-oversubscribed-5-7-million-seed-funding-to-make-doula-care-the-standard-in-maternal-health

Flourish Care Raises Oversubscribed $5. 7 Million Seed Funding to Make Doula Care the Standard in Maternal Health | Weekly Voice

2+ week, 3+ day ago  (101+ words) Flourish Care Raises Oversubscribed $5. 7 Million Seed Funding to Make Doula Care the Standard in Maternal Health'weeklyvoice. com The Largest South Asian News Platforms since 1997 BOSTON(BUSINESS WIRE) #Fem Tech Flourish Care, the maternal healthcare platform with the leading doula network,…...

Weekly Voice
weeklyvoice. com > enhertu-plus-pertuzumab-type-ii-variation-application-validated-in-the-eu-as-first-line-treatment-of-patients-with-her2-positive-metastatic-breast-cancer

ENHERTU" Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

2+ mon, 3+ week ago  (59+ words) Weekly Voice The Largest South Asian News Platforms since 1997 TOKYO & MUNICH(BUSINESS WIRE)ENHERTU Plus Pertuzumab Type II Variation Application Validated in EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer...